Ophthalmology Doctors in Chesapeake, VA Accepting Medicare

8 Ophthalmology doctors found. Showing 1 - 8

Dr. Robert E Baker, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3206 Churchland Blvd, Chesapeake, VA 23321 Phone: 757-484-0101    Fax: 757-484-0515

Fredric Jay Gross, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 109 Wimbledon Sq, Ste E, Chesapeake, VA 23320 Phone: 757-547-9830    Fax: 757-548-0721

Richard Thomas Griffey, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 508 Baylor Ct, Ste C, Chesapeake, VA 23320 Phone: 757-410-9500    Fax: 757-410-9507

Steven Keith Snyder, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 109 Wimbledon Sq, Ste E, Chesapeake, VA 23320 Phone: 757-547-9830    Fax: 757-548-0721

Leland D Whitelock, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 560 Kempsville Rd, Suite 100, Chesapeake, VA 23320 Phone: 757-410-9500    Fax: 757-410-9507

Paul M Griffey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 560 Kempsville Rd, Suite 100, Chesapeake, VA 23320 Phone: 757-410-9500    Fax: 757-410-9507

Dr. Shakur Hamidi Toosi, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Pkwy Ste 209, Chesapeake, VA 23320 Phone: 757-547-9751    Fax: 757-547-1876

Dr. Michael Raymond Keverline, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3206 Churchland Blvd, Chesapeake, VA 23321 Phone: 757-484-0101    Fax: 757-484-0515

News Archive

Boehringer Ingelheim receives FDA Priority Review for afatinib to treat EGFR mutation-positive NSCLC

Boehringer Ingelheim today announced that the New Drug Application (NDA) for its investigational oncology compound afatinib has been accepted for filing and granted Priority Review by the U.S. Food and Drug Administration (FDA).

Kona Medical raises $30 million in Series C financing

Kona Medical, Inc. today announced it has raised $30 million in Series C financing to advance its novel hypertension therapy.

Multi-site study of noninvasive brain stimulation to improve upper limb function after spinal cord injury

Kessler Foundation is one of three sites participating in a study of noninvasive brain stimulation to improve upper limb function funded by the U.S. Department of Defense Congressionally Directed Medical Research Programs titled, "Improving Spinal Cord Injury Rehabilitation Interventions by Retraining the Brain." Ela Plow, PhD, is principal investigator for the Cleveland Clinic; Svetlana Pundik, PhD, is principal investigator for the Louis B. Stokes VA Cleveland Medical Center; and Gail Forrest, PhD, is principal investigator for the Foundation, which received a sub-award of $778,000. Dr. Forrest is director of the new Center for Spinal Stimulation at Kessler Foundation.

UT Southwestern study suggests potential way to prevent Alzheimer's disease

A study by UT Southwestern researchers finds that changing the biochemistry of parts of brain cells abolished the formation of amyloid beta plaques in a mouse model of Alzheimer's disease.

Impact of racial discrimination in moderate-to-heavy drinking adult Latinxs

University of Houston associate professor of psychology Andres Viana has received a $900,000 Mentored Patient-Oriented Research Career Development Award from the National Institute on Alcohol Abuse and Alcoholism to examine the impact of racial discrimination in moderate-to-heavy drinking adult Latinxs. Viana prefers the gender-neutral term Latinx.

Read more Medical News

› Verified 9 days ago